Status:
COMPLETED
Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT
Lead Sponsor:
Evangelisches Krankenhaus Bielefeld gGmbH
Conditions:
Borderline Personality Disorder
Psychotherapy
Eligibility:
All Genders
18-65 years
Brief Summary
Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic inf...
Eligibility Criteria
Inclusion
- three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)
Exclusion
- inability to contract and consent,
- other severe mental disorders (bipolar disorder, acute psychosis),
- current alcohol,
- illicit or not prescribed drug use,
- simultaneous participation in other treatment studies,
- pregnancy or breastfeeding,
- an inability to negotiate a non-suicide agreement,
- ongoing traumatic contact with the perpetrator, and
- a Body Mass Index \< 16.5.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05289583
Start Date
January 1 2019
End Date
February 28 2022
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Department
Bielefeld, Germany